Acute biphenotypic leukemia in the adults.
- Author:
Yimin SHEN
1
;
Jianyong LI
;
Yongquan XUE
;
Mingqing ZHU
;
Dingwei LU
;
Meiju GENG
;
Changgeng RUAN
Author Information
- Publication Type:Journal Article
- MeSH: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cytogenetics; Female; Humans; Leukemia, Myeloid; drug therapy; genetics; immunology; physiopathology; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; drug therapy; genetics; immunology; physiopathology
- From: Chinese Journal of Oncology 2002;24(4):375-377
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the clinical, biological features and prognosis of acute biphenotypic leukemia (BAL) in the adults.
METHODSBone marrow specimens of 63 BAL patients were evaluated to prove the diagnosis and the classification by morphologic, cytochemical, immunologic and cytogenetic (MIC) examinations. These patients were treated with protocols suitable for acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL), or both.
RESULTSNo significant difference in clinical features was observed between BAL, AML or ALL. Morphologically, the subtypes of M(5), M(1) and M(2) were predominant in AML, as L(2) and L(1) were in ALL. Immunologically, coexpression of myeloid and B lineage associated antigens was predominant and CD(34) was hyperexpressed in BAL, which suggested that BAL might originate from malignant transformation of earlier hematopoietic cells. Cytogenetically, Ph chromosome was observed in 25.5% (13/51) of BAL patients. Prognostically, both the treatment response and the overall survival of BAL patients were poor.
CONCLUSIONPatients with BAL have unique clinical, biological and prognostic features.
